BIOMAT Database Logo BIOMAT Database Logo

Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets. 1980

K Suzuki, and J Nishioka, and S Hashimoto

UI MeSH Term Description Entries
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

K Suzuki, and J Nishioka, and S Hashimoto
Binding of porcine von Willebrand factor to human platelets in the presence of ristocetin.
June 1982, Thrombosis research,
K Suzuki, and J Nishioka, and S Hashimoto
Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
August 1982, Blood,
K Suzuki, and J Nishioka, and S Hashimoto
Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
July 1980, The Journal of laboratory and clinical medicine,
K Suzuki, and J Nishioka, and S Hashimoto
Ristocetin and von Willebrand factor analysis.
July 1987, Medical laboratory sciences,
K Suzuki, and J Nishioka, and S Hashimoto
Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.
May 1991, The Journal of biological chemistry,
K Suzuki, and J Nishioka, and S Hashimoto
Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets.
December 2017, Arteriosclerosis, thrombosis, and vascular biology,
K Suzuki, and J Nishioka, and S Hashimoto
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
November 2008, European journal of haematology,
K Suzuki, and J Nishioka, and S Hashimoto
von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
December 1979, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
K Suzuki, and J Nishioka, and S Hashimoto
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?
March 2001, British journal of haematology,
K Suzuki, and J Nishioka, and S Hashimoto
Interaction of ristocetin and von Willebrand factor.
June 1976, Thrombosis and haemostasis,
Copied contents to your clipboard!